dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Gudiol, Carlota |
dc.contributor.author | Durà-Miralles, X. |
dc.contributor.author | Aguilar-Company, Juan |
dc.contributor.author | Hernández-Jiménez, P. |
dc.contributor.author | Martínez-Cutillas, M. |
dc.contributor.author | Fernández-Avilés, Francesc |
dc.date.accessioned | 2022-01-25T11:38:06Z |
dc.date.available | 2022-01-25T11:38:06Z |
dc.date.issued | 2021-09 |
dc.identifier.citation | Gudiol C, Durà-Miralles X, Aguilar-Company J, Hernández-Jiménez P, Martínez-Cutillas M, Fernandez-Avilés F, et al. Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study. J Infect. 2021 Sep;83(3):306–13. |
dc.identifier.issn | 0163-4453 |
dc.identifier.uri | https://hdl.handle.net/11351/6888 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Complicacions infeccioses; Càncer |
dc.description.sponsorship | This study was supported by the Spanish Plan Nacional de IDi 2013-2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, and the Spanish Network for Research in Infectious Diseases (REIPI grant: RD16/0016/0001). It was also co-financed by the European Development Regional Fund ‘A Way to Make Europe’, Operational Programme Smart Growth 2014-2020. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Journal of Infection;83(3) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | COVID-19 (Malaltia) |
dc.subject | Càncer - Complicacions |
dc.subject | Infeccions oportunistes |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /complications |
dc.subject.mesh | Coinfection |
dc.title | Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.jinf.2021.07.014 |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | neoplasias |
dc.subject.decs | /complicaciones |
dc.subject.decs | coinfección |
dc.relation.publishversion | https://doi.org/10.1016/j.jinf.2021.07.014 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Gudiol C] Department of Infectious Diseases, Biostatistics Unit, Bellvitge University Hospital, Bellvitge Institute for Biomedical Research (IDIBELL), University of Barcelona, Barcelona, Spain. Institut Català d’Oncologia, IDIBELL, University of Barcelona, Barcelona, Spain. Spainsh Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Durà-Miralles X] Department of Infectious Diseases, Biostatistics Unit, Bellvitge University Hospital, Bellvitge Institute for Biomedical Research (IDIBELL), University of Barcelona, Barcelona, Spain. Spainsh Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Aguilar-Company J] Servei d’Oncologia Mèdica; Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Hernández-Jiménez P] Infectious Diseases Unit, 12 de Octubre University Hospital, Madrid, Spain. [Martínez-Cutillas M] Medical Oncology Department, Puerta de Hierro University Hospital, Madrid, Spain. [Fernandez-Avilés F] Bone Marrow Transplantation Unit, Department of Haematology, Hospital Clinic of Barcelona, Spain |
dc.identifier.pmid | 34302864 |
dc.identifier.wos | 000690346900009 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |